Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Mar;37(3):192–196. doi: 10.1136/jmg.37.3.192

A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer

J Gray 1, K Brain 1, P Norman 1, C Anglim 1, L France 1, G Barton 1, L Branston 1, E Parsons 1, A Clarke 1, J Sampson 1, E Roberts 1, R Newcombe 1, D Cohen 1, C Rogers 1, R Mansel 1, P Harper 1
PMCID: PMC1734533  PMID: 10699055

Abstract

Randomised controlled trials allow comparisons to be made between different models of service delivery, but have not been used in the field of clinical genetics. With the advent of clinical governance, the evidence provided by such trials will be increasingly important in informing and shaping clinical genetics practice. The TRACE project (Trial of genetic assessment in breast cancer) is a randomised controlled trial of genetic assessment for women who are at increased risk of breast cancer because of their family history. The absence of cancer genetics service provision in Wales before this study gave a window of opportunity in which this important trial could be conducted. The present paper describes how TRACE will provide crucial evidence regarding the psychosocial as well as resource implications of adding individualised genetic assessment, genetic counselling, and (where appropriate) gene testing to typical advice and surveillance from a hospital breast clinic. In addition, it is anticipated that TRACE will represent a model for future trials of service delivery in the increasing number of complex genetic disorders where evidence on the economic implications of screening and management is currently limited.


Keywords: genetic assessment; family history; breast cancer

Full Text

The Full Text of this article is available as a PDF (108.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. E. A genetic study of human breast cancer. J Natl Cancer Inst. 1972 Apr;48(4):1029–1034. [PubMed] [Google Scholar]
  2. Ball D. M., Harper P. S. Presymptomatic testing for late-onset genetic disorders: lessons from Huntington's disease. FASEB J. 1992 Jul;6(10):2818–2819. doi: 10.1096/fasebj.6.10.1386046. [DOI] [PubMed] [Google Scholar]
  3. Campbell H., MacKay J., Porteous M. The future of breast and ovarian cancer clinics. BMJ. 1995 Dec 16;311(7020):1584–1585. doi: 10.1136/bmj.311.7020.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Claus E. B., Risch N., Thompson W. D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991 Feb;48(2):232–242. [PMC free article] [PubMed] [Google Scholar]
  5. Easton D. F., Bishop D. T., Ford D., Crockford G. P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993 Apr;52(4):678–701. [PMC free article] [PubMed] [Google Scholar]
  6. Eeles R. Testing for the breast cancer predisposition gene, BRCA1. BMJ. 1996 Sep 7;313(7057):572–573. doi: 10.1136/bmj.313.7057.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990 Dec 21;250(4988):1684–1689. doi: 10.1126/science.2270482. [DOI] [PubMed] [Google Scholar]
  8. King M. C., Rowell S., Love S. M. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA. 1993 Apr 21;269(15):1975–1980. [PubMed] [Google Scholar]
  9. Lerman C., Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med. 1994 Mar 28;154(6):609–616. [PubMed] [Google Scholar]
  10. Lynch H. T., Watson P., Conway T. A., Lynch J. F., Slominski-Caster S. M., Narod S. A., Feunteun J., Lenoir G. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med. 1993 Sep 13;153(17):1979–1987. [PubMed] [Google Scholar]
  11. McPherson K., Steel C. M., Dixon J. M. ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics. BMJ. 1994 Oct 15;309(6960):1003–1006. doi: 10.1136/bmj.309.6960.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  13. Struewing J. P., Abeliovich D., Peretz T., Avishai N., Kaback M. M., Collins F. S., Brody L. C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 1995 Oct;11(2):198–200. doi: 10.1038/ng1095-198. [DOI] [PubMed] [Google Scholar]
  14. Wooster R., Neuhausen S. L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994 Sep 30;265(5181):2088–2090. doi: 10.1126/science.8091231. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES